Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 20 08 2019
accepted: 18 11 2019
entrez: 27 12 2019
pubmed: 27 12 2019
medline: 9 4 2020
Statut: epublish

Résumé

To date, little is known about differences in the knowledge, diagnosis making and treatment strategies of health care providers regarding polycystic ovary syndrome (PCOS) across different disciplines in countries with similar health care systems. To inform guideline translation, we aimed to study physician reported awareness, diagnosis and management of PCOS and to explore differences between medical disciplines in the Nordic countries and Estonia. This cross-sectional survey was conducted among 382 endocrinologists and obstetrician-gynaecologists in the Nordic countries and Estonia in 2015-2016. Of the participating physicians, 43% resided in Finland, 18% in Denmark, 16% in Norway, 13% in Estonia, and 10% in Sweden or Iceland, and 75% were obstetrician-gynaecologists. Multivariable logistic regression models were run to identify health care provider characteristics for awareness, diagnosis and treatment of PCOS. Clinical features, lifestyle management and comorbidity were commonly recognized in women with PCOS, while impairment in psychosocial wellbeing was not well acknowledged. Over two-thirds of the physicians used the Rotterdam diagnostic criteria for PCOS. Medical endocrinologists more often recommended lifestyle management (OR = 3.6, CI 1.6-8.1) or metformin (OR = 5.0, CI 2.5-10.2), but less frequently OCP (OR = 0.5, CI 0.2-0.9) for non-fertility concerns than general obstetrician-gynaecologists. The physicians aged <35 years were 2.2 times (95% CI 1.1-4.3) more likely than older physicians to recommend lifestyle management for patients with PCOS for fertility concerns. Physicians aged 46-55 years were less likely to recommend oral contraceptive pills (OCP) for patients with PCOS than physicians aged >56 (adjusted odds ratio (OR) = 0.4, 95% CI 0.2-0.8). Despite well-organized healthcare, awareness, diagnosis and management of PCOS is suboptimal, especially in relation to psychosocial comorbidities, among physicians in the Nordic countries and Estonia. Physicians need more education on PCOS and evidence-based information on Rotterdam diagnostic criteria, psychosocial features and treatment of PCOS, with the recently published international PCOS guideline well needed and welcomed.

Identifiants

pubmed: 31877155
doi: 10.1371/journal.pone.0226074
pii: PONE-D-19-23460
pmc: PMC6932801
doi:

Substances chimiques

Contraceptives, Oral 0
Metformin 9100L32L2N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0226074

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Curr Treat Options Cardiovasc Med. 2011 Aug;13(4):289-301
pubmed: 21562798
Hum Reprod. 2017 May 1;32(5):1075-1091
pubmed: 28333286
J Clin Endocrinol Metab. 2014 Jan;99(1):E107-11
pubmed: 24178791
Health Care Anal. 1999;7(4):321-30
pubmed: 10787795
Semin Reprod Med. 2018 Jan;36(1):19-27
pubmed: 30189447
Hum Reprod. 2018 Sep 1;33(9):1602-1618
pubmed: 30052961
Semin Reprod Med. 2018 Jan;36(1):5-12
pubmed: 30189445
Int J Endocrinol Metab. 2017 Jan 22;15(1):e43695
pubmed: 28835764
Eur J Endocrinol. 2014 Oct;171(4):489-98
pubmed: 25049203
Fertil Steril. 2017 Jun;107(6):1380-1386.e1
pubmed: 28483503
J Family Reprod Health. 2016 Jun;10(2):92-8
pubmed: 27648099
Clin Endocrinol (Oxf). 2018 Dec;89(6):683-699
pubmed: 30099747
Intern Med J. 2014 Aug;44(8):720-6
pubmed: 24909750
Oncotarget. 2017 Jul 12;8(56):96351-96358
pubmed: 29221211
Int J Endocrinol. 2018 Nov 14;2018:7234543
pubmed: 30538744
Hum Reprod Update. 2010 Jul-Aug;16(4):347-63
pubmed: 20159883
Lancet. 2018 Jun 2;391(10136):2236-2271
pubmed: 29893224
Fertil Steril. 2019 Aug;112(2):353-361
pubmed: 31056307
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1861-1869
pubmed: 28323926
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Hum Reprod. 2016 Dec;31(12):2841-2855
pubmed: 27664216
Med J Aust. 2018 Oct 1;209(S7):S3-S8
pubmed: 30453865

Auteurs

Terhi T Piltonen (TT)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.

Maria Ruokojärvi (M)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.

Helle Karro (H)

Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Tartu, Tartu, Estonia.

Linda Kujanpää (L)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.

Laure Morin-Papunen (L)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.

Juha S Tapanainen (JS)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.
Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Elisabet Stener-Victorin (E)

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Inger Sundrström-Poromaa (I)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Angelica L Hirschberg (AL)

Department of Women's and Children's Health, Karolinska Institutet and Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

Pernille Ravn (P)

Department of Gynaecology and Obstetrics, Odense University Hospital, Odense, Denmark.

Dorte Glintborg (D)

Department of Endocrinology, Odense University Hospital, Odense, Denmark.

Jan Roar Mellembakken (JR)

Department of Reproductive Medicine, Division of Gynaecology and Obstetrics, Oslo University Hospital, Oslo, Norway.

Thora Steingrimsdottir (T)

Department of Obstetrics and Gynecology, Landspitali University Hospital, School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Melanie Gibson-Helm (M)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Eszter Vanky (E)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Obstetrics and Gynecology, St Olav's Hospital, University Hospital of Trondheim, Trondheim, Norway.

Marianne Andersen (M)

Department of Language and Culture, UiT-The Arctic University of Norway, Tromsø, Norway.

Riikka K Arffman (RK)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.

Helena Teede (H)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Kobra Falah-Hassani (K)

Department of Obstetrics and Gynaecology, University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH